We are live on ! Find out more
BMED icon

iShares Health Innovation Active ETF

5 hedge funds and large institutions have $639K invested in iShares Health Innovation Active ETF in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,248% more capital inflows, than outflows

Capital inflows: $252K | Capital outflows: $18.7K

5.86% more ownership

Funds ownership: 10.12% → 15.98% (+5.9%)

0% more funds holding

Funds holding: 5 → 5 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$18.7K

BMED Hedge Fund Activity: Q2 2024 in Review

5 of the 6,946 institutional investors tracked by Wall St. Rank reported a position in iShares Health Innovation Active ETF (BMED) for Q2 2024, worth a combined $639K — up 50% from $427K a quarter earlier.

Fund positioning in BMED was balanced in Q2 2024: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $167K. The largest seller was Morgan Stanley, exiting entirely with an estimated $18.7K sold.

  • 5 institutional investors held iShares Health Innovation Active ETF (BMED) as of Q2 2024, unchanged from Q1 2024.
  • Funds reported $639K of iShares Health Innovation Active ETF stock for Q2 2024, up 50% quarter-over-quarter.
  • 1 fund opened new iShares Health Innovation Active ETF positions in Q2 2024 and 1 closed out, a net change of 0 holders.
  • The largest iShares Health Innovation Active ETF buyer in Q2 2024 was Citadel Advisors, an estimated $167K added.
  • The largest iShares Health Innovation Active ETF seller in Q2 2024 was Morgan Stanley, an estimated $18.7K sold.

Based on aggregated 13F filings for Q2 2024.